Antimicrobial activities of synthesized and characterized 5-acetyl pyrimidine-2, 4, 6-(1H, 3H, 5H)-trione based chalcones

Der Pharma Chemica

Volumn 4, Issue 1, 2012, Pages 141-146

  Dhorajiya, Bhavesh D ^a   Malani, Mahesh H ^a   Patel, Jigar R ^a   Dholakiya, Bharat Z ^a  

^a SARDAR VALLABHBHAI NATIONAL INSTITUTE OF TECHNOLOGY   (India)

Author keywords

5 acetyl pyrimidine 2, 4, 6 (1h, 3h, 5H) trione based chalcone; Antibacterial activity; Antifungal activity

Indexed keywords

5 ACETYL PYRIMIDINE 2,4,6 (1H,3H,5H) TRIONE BASED CHALCONE DERIVATIVE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CHALCONE DERIVATIVE; CIPROFLOXACIN; FLUCONAZOLE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL STRAIN; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; FUNGAL STRAIN; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYSICAL CHEMISTRY; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS;

EID: 84860874173     PISSN: None     EISSN: 0975413X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. H. S. Basavaraja, K. V. Jayadevaiah, M. M. Hussain, M. M. J. VijayKumar, J. Pharm. Sci. & Res. (2010), 2, 1, 5-12.
2. A. E. F. Omar, M. H. A. Eman, A. M. Neama, I. A. E. Sherien. Australian J. of Basic and Applied Sciences, (2010), 4, 1, 27-36.
3. S. J. Branko, M. N. Donna, Tetrahedron Letters. (2001), 42, 8435-8439.
4. C. B. Patil, S. K. Mahajan, S. A. Katti, J Pharm Sci Res. (2009), 1, 11-22.
5. E. T. Ogansyan, Khim. Farm. Zh. (1991), 25, 8, 18.
6. E. T. Ogansyan, Chem. Abstr., 115, 247497n (1991).
7. D. Binder, C. R. Noe, W. Holzer, B. Rosenwirth; Arch. Pharm.,(1985), 318, 1, 48.
8. D. Binder, C. R. Noe, W. Holzer, B. RosenwirthChem. Abstr., 102, 149025u (1985).
9. S. Cheenpracha, C. Karalai, S, Tewtrakul, Bioorganic & Medicinal Chemistry. (2006), 14, 6, 1710-1714.
10. S. Satoshi, N. Yasunori, U. Hiroki J. Med. Chem., 3904-9 (Eng.) (1993), Chem. Abstr., 120, 133956j (1994).
11. F. S. Nielsen, S. B. Chirstensen; Med. Chem. (1998), 41, 4819-4832.
12. Nissan Chemical Industries Ltd., Japan Kokai Tokkyo Koho Japan, (1983), 58, 08,035.
13. Chem. Abstr., 98, 178947a (1983).
14. R. Seele et al. Eur. Pat. Appl. Ep., (1989), 337, 198.
15. R. Seele et al. Chem. Abstr., 113, 178990s (1990).
16. Tashio Pharmaceutical Co. Ltd.; Japan, kokai Tokkyo Koho Jp., (1984), 59, 12, 094.
17. Chem. Abstr., 101, 54722j (1984).
18. K. Bowden, P. A. Dal, C. K. Shah, J. Chem. Res. Synop. (1990), 12, 2801.
19. K. Bowden, P. A. Dal, C. K. Shah, Chem. Abstr., 114, 160570m (1991).
20. Y. Inamori et al. Chem. Pharm. Bull. (1991), 39, 6, 1604.
21. Y. Inamori et al. Chem. Abstr., 115, 105547c (1991).
22. V. M. Gaurav, D. B. Ingle; Indian J. Chem., (1986), 25B, 868.
23. V. M. Gaurav, D. B. Chem. Abstr., 107, 39321h (1987).
24. A. K. Pedersen and G. A. Fitz Gerald; J. Pharm. Sci., (1985), 74, 2, 188.
25. A. K. Pedersen and G. A. Chem. Abstr., 103, 87592m (1985).
26. M. R. Bell; US Appl., (1984), 637, 931.
27. M. R. Bell; Chem. Abstr., 113, 211828t (1990).
28. Jacobson, (1937), U. S. pat. 2,090, 594, [C. A. 31, 7068].
29. B. Z. Dholakiya, J. R. Patel, Der Pharma Chemica, (2011), 3, 1,458-466.
30. A. Rattann, Antimicrobials in Laboratory Medicine, B. Churchill Livingstone, New Delhi, (2000), 85.
31. R. M. Silverstein, F. X. Webster, Spectrophotometric identification of organic compounds, John Willey & Sons, Canada, (1997), Sixth edition, 79-223.